215 related articles for article (PubMed ID: 32338281)
41. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
42.
Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
[TBL] [Abstract][Full Text] [Related]
43. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
44. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Ress AL; Stiegelbauer V; Schwarzenbacher D; Deutsch A; Perakis S; Ling H; Ivan C; Calin GA; Rinner B; Gerger A; Pichler M
Oncotarget; 2014 Sep; 5(18):8492-502. PubMed ID: 25261368
[TBL] [Abstract][Full Text] [Related]
45. Cinnamaldehyde enhances apoptotic effect of oxaliplatin and reverses epithelial-mesenchymal transition and stemnness in hypoxic colorectal cancer cells.
Wu CE; Zhuang YW; Zhou JY; Liu SL; Wang RP; Shu P
Exp Cell Res; 2019 Oct; 383(1):111500. PubMed ID: 31306656
[TBL] [Abstract][Full Text] [Related]
46. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
47. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
48. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
49. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
50. POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients.
Wang M; Niu W; Hu R; Wang Y; Liu Y; Liu L; Zhong J; Zhang C; You H; Zhang J; Lu L; Wei L; Xiao W
Mol Carcinog; 2019 May; 58(5):735-748. PubMed ID: 30582221
[TBL] [Abstract][Full Text] [Related]
51. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
[TBL] [Abstract][Full Text] [Related]
52. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.
Wang W; Wang H; Xiang L; Ni T; Jin F; Deng J; Zhang Y; Shintaro I; Zhou Y; Liu Y
Oncol Rep; 2020 Jul; 44(1):77-90. PubMed ID: 32627002
[TBL] [Abstract][Full Text] [Related]
53. KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer.
Ukai S; Sakamoto N; Taniyama D; Harada K; Honma R; Maruyama R; Naka K; Hinoi T; Takakura Y; Shimizu W; Ohdan H; Yasui W
Cancer Sci; 2021 Mar; 112(3):1196-1208. PubMed ID: 33423358
[TBL] [Abstract][Full Text] [Related]
54. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
Yan X; Huang L; Liu L; Qin H; Song Z
Cancer Med; 2018 Feb; 7(2):420-432. PubMed ID: 29341479
[TBL] [Abstract][Full Text] [Related]
55. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G
Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230
[TBL] [Abstract][Full Text] [Related]
56. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
[TBL] [Abstract][Full Text] [Related]
57. INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling.
Ding X; Chen T; Shi Q; Nan P; Wang X; Xie D; Li J
Exp Cell Res; 2021 Oct; 407(2):112826. PubMed ID: 34508742
[TBL] [Abstract][Full Text] [Related]
58. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
59. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
Wang G; Gu J; Gao Y
Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
